The association between HPV infection and endometriosis: Risk and fertility outcomes

Abstract

While infections have been implicated in endometriosis pathogenesis, the role of human papillomavirus (HPV) remains unclear. This study combined a meta-analysis of seven studies with a case-control study (n = 432 surgically treated patients) to evaluate the association of HPV infection with endometriosis risk and fertility outcomes. The meta-analysis showed no significant association between HPV infection and endometriosis risk, either for any HPV subtype (pooled odds ratio [OR] = 2.60, 95% confidence interval [CI]: 0.28-23.87) or high-risk subtypes (OR = 1.68, 95% CI: 0.49-5.75). Notably, HPV prevalence was higher in patients with endometriosis (46% overall; 36% for high-risk subtypes) than in the general population. Evidence regarding the association between HPV infection and fertility outcomes remains limited, with only two eligible studies identified. Our case-control analysis revealed that HPV-positive patients had significantly reduced postoperative live birth rates compared with HPV-negative counterparts (10.6% vs. 21.0%, P < 0.05). These findings suggest that HPV infection is unlikely to be a major risk factor for endometriosis development, but it may be associated with poorer postsurgical fertility outcomes. The dual-method approach strengthens the evidence for HPV's clinical impact on reproductive prognosis in patients with existing endometriosis.

Keywords

human papillomavirus / endometriosis / female infertility / pregnancy outcomes / meta-analysis / case-control analysis

References

[1] Flores I, Abreu S, Abac S, et al. Self-reported prevalence of endometriosis and its symptoms among Puerto Rican women[J]. Int J Gynaecol Obstet, 2008, 100(3): 257-261. doi: 10.1016/j.ijgo.2007.08.010

[2] Ballard KD, Seaman HE, de Vries CS, et al. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study-Part 1[J]. BJOG, 2008, 115(11): 1382-1391. doi: 10.1111/j.1471-0528.2008.01878.x

[3] Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis[J]. BMJ, 2022, 379: e070750. doi: 10.1136/bmj-2022-070750

[4] Koninckx PR, Ussia A, Tahlak M, et al. Infection as a potential cofactor in the genetic-epigenetic pathophysiology of endometriosis: A systematic review[J]. Facts Views Vis Obgyn, 2019, 11(3): 209-216. https://pmc.ncbi.nlm.nih.gov/articles/PMC7020943/

[5] Muraoka A, Suzuki M, Hamaguchi T, et al. Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts[J]. Sci Transl Med, 2023, 15(700): eadd1531. doi: 10.1126/scitranslmed.add1531

[6] Lee CA, Huang CTF, King A, et al. Differential effects of human papillomavirus DNA types on p53 tumor-suppressor gene apoptosis in sperm[J]. Gynecol Oncol, 2002, 85(3): 511-516. doi: 10.1006/gyno.2002.6662

[7] Foresta C, Garolla A, Zuccarello D, et al. Human papillomavirus found in sperm head of young adult males affects the progressive motility[J]. Fertil Steril, 2010, 93(3): 802-806. doi: 10.1016/j.fertnstert.2008.10.050

[8] Zullo F, Fiano V, Gillio-Tos A, et al. Human papillomavirus infection in women undergoing in-vitro fertilization: Effects on embryo development kinetics and live birth rate[J]. Reprod Biol Endocrinol, 2023, 21(1): 39. doi: 10.1186/s12958-023-01091-9

[9] van Hamont D, Nissen LHC, Siebers AG, et al. Abnormal cervical cytology in women eligible for IVF[J]. Hum Reprod, 2006, 21(9): 2359-2363. doi: 10.1093/humrep/del132

[10] Depuydt CE, Verstraete L, Berth M, et al. Human papillomavirus positivity in women undergoing intrauterine insemination has a negative effect on pregnancy rates[J]. Gynecol Obstet Invest, 2016, 81(1): 41-46. doi: 10.1159/000434749

[11] Perino A, Giovannelli L, Schillaci R, et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: Impact on reproductive outcomes[J]. Fertil Steril, 2011, 95(5): 1845-1848. doi: 10.1016/j.fertnstert.2010.11.047

[12] Wang Y, Wang C, Qiao J, et al. Relationship of cytopathology and cervical infection to outcome of in-vitro fertilization and embryo transfer[J]. Int J Gynaecol Obstet, 2008, 101(1): 21-26. doi: 10.1016/j.ijgo.2007.09.035

[13] Oppelt P, Renner SP, Strick R, et al. Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions[J]. Fertil Steril, 2010, 93(6): 1778-1786. doi: 10.1016/j.fertnstert.2008.12.061

[14] Vestergaard AL, Knudsen UB, Munk T, et al. Low prevalence of DNA viruses in the human endometrium and endometriosis[J]. Arch Virol, 2010, 155(5): 695-703. doi: 10.1007/s00705-010-0643-y

[15] Rocha RM, Souza RP, Gimenes F, et al. The high-risk human papillomavirus continuum along the female reproductive tract and its relationship to infertility and endometriosis[J]. Reprod Biomed Online, 2019, 38(6): 926-937. doi: 10.1016/j.rbmo.2018.11.032

[16] Heidarpour M, Derakhshan M, Derakhshan-Horeh M, et al. Prevalence of high-risk human papillomavirus infection in women with ovarian endometriosis[J]. J Obstet Gynaecol Res, 2017, 43(1): 135-139. doi: 10.1111/jog.13188

[17] Hong YS, Park J, Kim H. Association of endometriosis with genital human papillomavirus infection in US women: A national population-based study[J]. Sci Rep, 2023, 13(1): 8020. doi: 10.1038/s41598-023-35153-0

[18] Moslehi Z, Derakhshan R, Chaichian S, et al. Correlation of high-risk human papilloma virus with deep endometriosis: A cross-sectional study[J]. Biomed Res Int, 2023, 2023: 6793898. doi: 10.1155/2023/6793898

[19] Okyay E, Kula H, Yavuz O, et al. The human papillomavirus and its relationship to infertility and endometriosis[J]. Clin Exp Obstet Gynecol, 2023, 50(8): 170. doi: 10.31083/j.ceog5008170

[20] American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996[J]. Fertil Steril, 1997, 67(5): 817-821. doi: 10.1016/S0015-0282(97)81391-X

[21] Adamson GD, Pasta DJ. Endometriosis fertility index: The new, validated endometriosis staging system[J]. Fertil Steril, 2010, 94(5): 1609-1615. doi: 10.1016/j.fertnstert.2009.09.035

[22] Matalliotakis M, Matalliotaki C, Zervou MI, et al. Coexistence of cervical endometriosis with premalignant and malignant gynecological pathologies: Report on a series of 27 cases[J]. Women Health, 2021, 61(9): 896-901. doi: 10.1080/03630242.2021.1991073

[23] Maria H, Dana H, Françoise M, et al. Human papillomaviruses in Western Africa: Prevalences and risk factors in Burkina Faso[J]. Arch Gynecol Obstet, 2018, 298(4): 789-796. doi: 10.1007/s00404-018-4860-z

[24] Wang J, Li H, Zhang J, et al. Epidemiology and genotypes analysis of human papillomavirus infection in Beijing, China[J]. Virol J, 2024, 21(1): 19. doi: 10.1186/s12985-024-02292-3

[25] Prabhu VS, Roberts CS, Kothari S, et al. Median age at HPV infection among women in the United States: A model-based analysis informed by real-world data[J]. Open Forum Infect Dis, 2021, 8(7): ofab111. doi: 10.1093/ofid/ofab111

[26] Hung M, Su S, Hon ES, et al. Health disparities associated with females reporting human papillomavirus infection in the United States[J]. Womens Health Rep (New Rochelle), 2021, 2(1): 245-253. doi: 10.1089/whr.2021.0036

[27] Shen Y, Xia J, Li H, et al. Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women[J]. BMC Womens Health, 2021, 21(1): 80. doi: 10.1186/s12905-021-01217-4

[28] Kitajima M, Khan KN, Harada A, et al. Association between ovarian endometrioma and ovarian reserve[J]. Front Biosci (Elite Ed), 2018, 10(1): 92-102. doi: 10.2741/e810

[29] Scutiero G, Iannone P, Bernardi G, et al. Oxidative stress and endometriosis: A systematic review of the literature[J]. Oxid Med Cell Longev, 2017, 2017: 7265238. doi: 10.1155/2017/7265238

[30] Calinisan JH, Chan SR, King A, et al. Human papillomavirus and blastocyst apoptosis[J]. J Assist Reprod Genet, 2002, 19(3): 132-136. doi: 10.1023/A:1014736805127

[31] Henneberg AA, Patton WC, Jacobson JD, et al. Human papilloma virus DNA exposure and embryo survival is stage-specific[J]. J Assist Reprod Genet, 2006, 23(6): 255-259. doi: 10.1007/s10815-006-9030-8

[32] Spandorfer SD, Bongiovanni AM, Fasioulotis S, et al. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome[J]. Fertil Steril, 2006, 86(3): 765-767. doi: 10.1016/j.fertnstert.2006.01.051